FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ciprofloxacin Hydrochloride Tablets
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Mylan Pharmaceuticals Inc. (New 09/08/2017)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Ciprofloxacin Hydrochloride Tablet 500mg, film coated (NDC 0378-7098-01) 09/08/2017 A business decision was made to discontinue manufacture of the drug product. This product discontinuation is not related to product quality, safety or efficacy.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English